Pulse Biosciences, Inc. has appointed Maria Sainz to its Board of Directors, effective January 9, 2026. Sainz brings over thirty years of experience in healthcare technology and currently serves as President and CEO of Hyperfine, Inc. She has previously held CEO and leadership roles at several medical device companies and served on multiple corporate boards.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260109615179) on January 09, 2026, and is solely responsible for the information contained therein.
Comments